Sleep Loss in Alzheimer’s Disease: Cause, Consequence, or a Clue to Something Much Bigger?

For years, we’ve recognized that people with Alzheimer’s disease sleep less. They have more fragmented sleep, spend less time in deep restorative sleep, and often awaken repeatedly throughout the night. But one critical question has remained unanswered:

Is poor sleep helping to cause Alzheimer’s disease, or is Alzheimer’s disease causing poor sleep?

The answer, as is often the case in biology, appears to be both. We already know that chronic sleep deprivation raises the risk of developing Alzheimer’s disease. But an important new study now sheds light on the opposite side of this relationship. Using a well-established mouse model of Alzheimer’s disease, researchers demonstrate that the sleep loss seen early in Alzheimer’s appears to be a consequence of the disease itself, and remarkably, that consequence is driven not by amyloid plaques directly, but by activation of the brain’s immune cells, the microglia. 

This finding resonates deeply with the central message of my upcoming book, Brain Defenders. The real story of Alzheimer’s is not simply about the accumulation of amyloid. Rather, it’s about how the brain’s immune system responds to those changes. Healthy, supportive microglia, the M2 phenotype I describe in Brain Defenders, protect neurons, maintain healthy synaptic connections, regulate neuronal metabolism, and help preserve normal brain function. But when these cells become chronically activated into a destructive inflammatory state, they begin disrupting the very brain networks they were designed to defend.

That’s exactly what this new research demonstrates. The investigators found that mice developing amyloid plaques lost approximately two hours of non-REM sleep each day. Surprisingly, once plaques appeared, adding many more plaques did not worsen the sleep loss. In other words, sleep disruption wasn’t proportional to amyloid burden. Instead, the appearance of plaques seemed to trigger an inflammatory response that fundamentally altered sleep regulation.

Now, here’s what’s most compelling. The researchers depleted the activated microglia using a well-described technique. The amyloid plaques remained in the brain, yet the animals regained more than two hours of sleep every day. Their sleep architecture normalized despite essentially unchanged amyloid pathology. That finding strongly suggests that the inflammatory response, as a consequence of the activation of the microglial cells, not the plaques themselves, was driving much of the sleep disruption.

It’s important to emphasize that this was an animal study. We cannot assume that eliminating microglia would be appropriate, or even desirable, in humans, although that technology is now being used in humans with a specific, lethal disease. Microglia perform countless essential functions, and simply removing them is certainly not a therapeutic strategy. But the study provides something arguably more valuable: a mechanism. It strongly supports the idea that microglial activation is responsible for at least part of the sleep disruption associated with Alzheimer’s disease.

And there is already human evidence pointing in the same direction. PET imaging studies using TSPO tracers have consistently shown that increased microglial activation in people with Alzheimer’s disease correlates with poorer sleep quality, greater neuroinflammation, and faster disease progression. Other human studies have demonstrated that even a single night of sleep deprivation increases amyloid levels in the brain, while chronic poor sleep predicts future cognitive decline years before symptoms appear. The relationship is clearly bidirectional. Poor sleep promotes inflammation and amyloid accumulation, while activated microglia and early Alzheimer’s pathology disrupt the brain’s ability to generate restorative sleep.

This may also help explain something that has puzzled researchers for years. People with obesity, insulin resistance, and type 2 diabetes frequently experience poor sleep. Traditionally, this has been attributed to factors such as sleep apnea, hormonal changes, or excess body weight. Those factors certainly matter. But metabolic dysfunction also activates microglia.

Over the past decade, research has repeatedly shown that elevated blood sugar, insulin resistance, visceral obesity, and systemic inflammation push microglia toward a pro-inflammatory state. In fact, one of the earliest changes seen in Alzheimer’s disease is metabolic reprogramming of these immune cells. They begin consuming energy differently, producing inflammatory cytokines, and altering communication between neurons long before significant cognitive symptoms appear.

Perhaps these seemingly separate observations are actually connected. If metabolic dysfunction activates microglia, and activated microglia interfere with the neural circuits governing sleep, then impaired sleep may represent yet another downstream consequence of unhealthy metabolism. That possibility fits remarkably well with what we already know about diabetes and obesity increasing dementia risk by as much as twofold.

In Brain Defenders, I describe microglia as the architects of the brain’s future. Every day they decide whether to defend or destroy. Their behavior is profoundly influenced by the choices we make, our diet, physical activity, sleep habits, exposure to nature, stress levels, and social connections.

This new study suggests something even more intriguing. By keeping microglia in their supportive, protective M2 state, we may not only reduce the long-term risk of neurodegeneration but also help preserve healthy sleep itself. While this particular study did not test lifestyle interventions, decades of research show that regular exercise, maintaining healthy blood sugar, reducing chronic inflammation, eating a Mediterranean-style diet, and obtaining restorative sleep all favor a healthier microglial phenotype.

Notice the positive feedback loop. Healthy metabolism supports healthy microglia. Healthy microglia help preserve healthy sleep. Healthy sleep then further reduces inflammation, improves glymphatic clearance, enhances insulin sensitivity, and helps maintain healthy microglia.

Conversely, poor diet, excess body fat, insulin resistance, and chronic inflammation may activate microglia, disrupt sleep, and accelerate the very brain changes we hope to prevent.

This is why I believe we’ve been looking at Alzheimer’s through too narrow a lens. Rather than focusing exclusively on removing amyloid after decades of damage have accumulated, we should be asking a much more empowering question: What keeps our brain’s immune cells functioning as defenders instead of becoming destroyers?

The answer may ultimately determine not only how well we think as we age, but also how well we sleep.